<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04818775</url>
  </required_header>
  <id_info>
    <org_study_id>HemaClear</org_study_id>
    <nct_id>NCT04818775</nct_id>
  </id_info>
  <brief_title>Use of Sterile HemaClear Tourniquet Below Calf Versus Pneumatic Tourniquet at the Thigh for Ankle and Foot Surgery</brief_title>
  <acronym>HemaClear</acronym>
  <official_title>Use of Sterile HemaClear Tourniquet Below Calf Versus Pneumatic Tourniquet at the Thigh for Ankle and Foot Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital do Coracao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital do Coracao</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Randomized controlled trial evaluating the effects of the use of Sterile HemaClear&#xD;
      Tourniquet Below Calf Versus Pneumatic Tourniquet at the Thigh for Ankle and Foot Surgery&#xD;
&#xD;
      The trial will randomize 60 patients into an experimental group with HemaClear or Active&#xD;
      comparator group with Pneumatic Tourniquet.&#xD;
&#xD;
      The outcomes are: effectiveness of the tourniquet, bleeding escapes, infection, deep vein&#xD;
      thrombosis, pain at the tourniquet site, neurologic problems related to the tourniquet&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">July 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>infection rates</measure>
    <time_frame>after 1 week</time_frame>
    <description>infection rates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infection rates</measure>
    <time_frame>after 3 months</time_frame>
    <description>infection rates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Deep vein thrombosis</measure>
    <time_frame>after 1 week</time_frame>
    <description>Deep vein thrombosis (Clinical assessment and Doppler ultrasound)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Deep vein thrombosis</measure>
    <time_frame>after 3 months</time_frame>
    <description>Deep vein thrombosis (Clinical assessment and Doppler ultrasound)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>local pain</measure>
    <time_frame>after 1 week</time_frame>
    <description>local pain at the tourniquet site (Visual Analogue Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local pain</measure>
    <time_frame>after 3 months</time_frame>
    <description>local pain at the tourniquet site (Visual Analogue Scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Foot Fracture</condition>
  <condition>Ankle Fractures</condition>
  <condition>Ankle Injuries</condition>
  <condition>Foot Injuries and Disorders</condition>
  <arm_group>
    <arm_group_label>HemaClear</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pneumatic Tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HemaClear</intervention_name>
    <description>HemaClear Model A</description>
    <arm_group_label>HemaClear</arm_group_label>
    <other_name>HemaClear Model A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pneumatic Tourniquet</intervention_name>
    <description>Pneumatic Tourniquet</description>
    <arm_group_label>Pneumatic Tourniquet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ankle and foot surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infection&#xD;
&#xD;
          -  Tumors&#xD;
&#xD;
          -  Open fracture&#xD;
&#xD;
          -  Burns&#xD;
&#xD;
          -  Varicose veins&#xD;
&#xD;
          -  Isquemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maur√≠cio P Barbosa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital do Coracao</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital do Coracao</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04005-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2021</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Foot Fracture</keyword>
  <keyword>Ankle Fractures</keyword>
  <keyword>Ankle Injuries</keyword>
  <keyword>Orthopaedic Devices Associated with Misadventures</keyword>
  <keyword>Foot Injuries and Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Ankle Fractures</mesh_term>
    <mesh_term>Ankle Injuries</mesh_term>
    <mesh_term>Foot Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

